Earth Life Sciences Inc. (CLTS)

Earth Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Selling, General & Admin	0.08	0.04	0.03	0.04	0.04	0.04
Operating Expenses	0.38	1.56	1.82	0.05	0.44	6.79
Operating Income	-0.38	-1.56	-1.82	-0.05	-0.44	-6.79
Interest Expense	-0.02	-0.02	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	-0.01	-	-
Pretax Income	-0.4	-1.58	-1.82	-0.05	-0.44	-6.79
Earnings From Continuing Operations	-0.4	-1.58	-1.82	-0.05	-0.44	-6.79
Net Income	-0.4	-1.58	-1.82	-0.05	-0.44	-6.79
Net Income to Common	-0.4	-1.58	-1.82	-0.05	-0.44	-6.79
Shares Outstanding (Basic)	852	495	438	333	333	271
Shares Outstanding (Diluted)	852	495	438	333	333	271
Shares Change (YoY)	77.21%	12.81%	31.68%	-	22.96%	0.07%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.03
Free Cash Flow	-0	-0.02	-0.02	-0.03	-	-
EBITDA	-	-	-1.82	-0.04	-0.44	-6.79
D&A For EBITDA	-	-	0	0	0	0
EBIT	-0.38	-1.56	-1.82	-0.05	-0.44	-6.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.